BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30839051)

  • 1. LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis.
    Song X; Liu Z; Yu Z
    Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):386-392. PubMed ID: 30839051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.
    Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W
    J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19.
    Wang N; Hou M; Zhan Y; Sheng X
    J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150.
    Luo H; Xu C; Le W; Ge B; Wang T
    J Cell Biochem; 2019 Aug; 120(8):13487-13493. PubMed ID: 30916832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC.
    Niu L; Fan Q; Yan M; Wang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication.
    Sheng X; Dai H; Du Y; Peng J; Sha R; Yang F; Zhou L; Lin Y; Xu S; Wu Y; Yin W; Lu J
    J Exp Clin Cancer Res; 2021 Jun; 40(1):205. PubMed ID: 34162418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
    Liu W
    Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
    [No Abstract]   [Full Text] [Related]  

  • 8. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a.
    Youness RA; Hafez HM; Khallaf E; Assal RA; Abdel Motaal A; Gad MZ
    J Cell Physiol; 2019 Nov; 234(11):20286-20297. PubMed ID: 30968427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death.
    Beltrán-Anaya FO; Romero-Córdoba S; Rebollar-Vega R; Arrieta O; Bautista-Piña V; Dominguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Alfaro-Riuz L; Jiménez-Morales S; Cedro-Tanda A; Ríos-Romero M; Reyes-Grajeda JP; Tagliabue E; Iorio MV; Hidalgo-Miranda A
    Mol Oncol; 2019 Apr; 13(4):909-927. PubMed ID: 30648789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
    Yan J; Wang R; Wu Z
    J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA DANCR contributes to tumor progression via targetting miR-216a-5p in breast cancer: lncRNA DANCR contributes to tumor progression.
    Tao W; Wang C; Zhu B; Zhang G; Pang D
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA NEF inhibits migration and invasion of HPV-negative cervical squamous cell carcinoma by inhibiting TGF-β pathway.
    Ju W; Luo X; Zhang N
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1.
    Wang J; Xi C; Yang X; Lu X; Yu K; Zhang Y; Gao R
    Cancer Biother Radiopharm; 2019 Dec; 34(10):671-675. PubMed ID: 31621381
    [No Abstract]   [Full Text] [Related]  

  • 15. Long non-coding RNA (LncRNA) RMST in triple-negative breast cancer (TNBC): Expression analysis and biological roles research.
    Wang L; Liu D; Wu X; Zeng Y; Li L; Hou Y; Li W; Liu Z
    J Cell Physiol; 2018 Oct; 233(10):6603-6612. PubMed ID: 29215701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C; Li X; Fan Q; Liu G; Yin J
    Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
    Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
    Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
    Vishnubalaji R; Alajez NM
    Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA HAND2-AS1 inhibits cancer cell proliferation, migration, and invasion in esophagus squamous cell carcinoma by regulating microRNA-21.
    Yan Y; Li S; Wang S; Rubegni P; Tognetti L; Zhang J; Yan L
    J Cell Biochem; 2019 Jun; 120(6):9564-9571. PubMed ID: 30520131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis.
    Zhang Y; Zhang H; Kang H; Huo W; Zhou Y; Zhang Y
    Int J Mol Med; 2019 Feb; 43(2):1049-1057. PubMed ID: 30483747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.